ClinicalTrials.gg
BiologicalDrug

Pelareorep clinical trials

Also written Reolysin and PO BB0209.

studies test it
30
open now
0
in phase 3
1
first study started
2006

How each study uses pelareorep is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Wild-type Reovirus
10
Pelareorep
8
Reovirus Serotype 3
3
reovirus serotype 3 Dearing Strain
3

Brand

Reolysin
24

Development codes

PO BB0209
3

Studies by the year they started

30 studies that test it; most in 2009 (4)

Studies that test pelareorep, by start year
YearStudies
20061
20071
20083
20094
20103
20124
20131
20141
20153
20173
20181
20202
20212
20221

Who runs them

Industry 14 · Other 16

Oncolytics Biotech (13) · National Cancer Institute (NCI) (5) · Canadian Cancer Trials Group (4) · University of Southern California (2) · University of Leeds (2) · Mridula George, MD (1) · Adlai Nortye Biopharma Co., Ltd. (1) · Mayo Clinic (1)

Often tested with

Tested in the same studies.

Paclitaxel (4) · Carboplatin (4) · Gemcitabine (2) · Retifanlimab (1) · Avelumab (1) · Folfox protocol (1) · FOLFOX-Bevacizumab Regimen (1) · Docetaxel/Prednisone Regimen (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test pelareorep.

Studies

Open first, then newest update. How each study uses pelareorep is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 30

See all 30 studies that test pelareorep →

Given beside what is tested · 5 — pelareorep is usual care or a partner of the new treatment

Codes

What other systems call pelareorep · ClinicalTrials.gg INT017881

  • UNII (FDA) S9J80L3D1UPELAREOREPOne source FDA
  • NCI Thesaurus C60774PelareorepOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.